Procter & Gamble Hygiene and Health Care Ltd posted profit at Rs 210.69 crore during its first quarter ended September 2023. This was up 36.4 per cent in comparison to Rs 154.41 crore during the same period last year. The profit increase was led by acceleration of volume growth coupled with product price-mix and productivity. During the quarter, the company delivered revenue from operations at Rs 1138.35 crore, up 8.9 per cent as against Rs 1044.89 crore during the quarter ended September 2022. The company EBITDA stood at Rs 284.9 crore, up 33 per cent on-year.
While the total income during the quarter was at Rs 1154.12 crore, the FMCG company incurred a total expenditure of Rs 869.65 crore. During the quarter, the company delivered a strong growth with sales increase of 9 per cent versus a year ago, driven by a superior retail execution and integrated growth strategy.
“We delivered a strong top and bottom-line growth in the quarter, by executing our integrated strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value —productivity, constructive disruption, and an agile and accountable organization. Our team’s execution of these strategies has enabled us to build momentum in the first quarter, and we are confident that these strategies will help us deliver balanced growth and value creation,” said LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd.
“The Company’s business continues to grow behind a strong product portfolio, superior consumer communication and a continuous stream of product innovations aimed at delighting consumers, like Whisper Hygiene Comfort, Whisper Choice Nights, Vicks ZzzQuil-World’s #1 Sleep Supplement, Vicks Roll-On Inhalerand Vicks Xtra Strong,” it said.